65 results
Page 3 of 4
8-K
cgkwc0 oz
26 Apr 23
Entry into a Material Definitive Agreement
8:30am
DEFA14A
wnyp p1uja
8 Dec 22
Additional proxy soliciting materials
8:31am
DEF 14A
i5qtz9 wm
25 Nov 22
Definitive proxy
6:16am
8-K
EX-10.1
vj45e3vek
18 Nov 22
Departure of Directors or Certain Officers
4:31pm
8-K
EX-1.1
265env
9 Nov 22
Entry into a Material Definitive Agreement
4:50pm
424B5
3fr dvof2hhwk
9 Nov 22
Prospectus supplement for primary offering
4:29pm
10-Q
bm0nvpngw9
8 Nov 22
Quarterly report
4:09pm
10-Q
EX-31.2
2xitm 692why
8 Nov 22
Quarterly report
4:09pm
10-Q
EX-31.1
y85fbrn
8 Nov 22
Quarterly report
4:09pm
8-K
EX-1.1
hvvyxcw
21 Oct 22
Entry into a Material Definitive Agreement
4:19pm
424B5
mudnqu0o69j nif7v
21 Oct 22
Prospectus supplement for primary offering
4:16pm
8-K
nekv bi1t
19 Oct 22
Jazz Pharmaceuticals and Zymeworks Announce Exclusive License Agreement to Develop and Commercialize Zanidatamab, a HER2-Targeted Bispecific Antibody
6:26am
424B5
ltkzuv9hu
13 Oct 22
Prospectus supplement for primary offering
4:56pm
8-K12B
EX-10.2
iz0ono
13 Oct 22
Notification of registration of securities
7:24am
8-K12B
EX-10.3
8krb42f5
13 Oct 22
Notification of registration of securities
7:24am
8-K12B
rb52l8kejrdbmq0n2tw
13 Oct 22
Notification of registration of securities
7:24am
8-K12B
EX-4.2
pp7f0
13 Oct 22
Notification of registration of securities
7:24am
8-K12B
EX-2.4
848ik1
13 Oct 22
Notification of registration of securities
7:24am
424B3
mlywl0e0eo9 2vjhf
2 Sep 22
Prospectus supplement
4:06pm
S-4/A
EX-99.8
tpu f32io7
19 Aug 22
Registration of securities issued in business combination transactions (amended)
4:47pm